Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.39 USD | -3.80% | +2.17% | +41.83% |
Mar. 19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
Mar. 15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.83% | 2.11B | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q3 Revenue $8,000